Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

51.10
Delayed Data
As of 4:00pm ET
 +1.22 / +2.45%
Today’s Change
40.32
Today|||52-Week Range
58.59
+21.38%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 70.00, with a high estimate of 117.00 and a low estimate of 35.00. The median estimate represents a +36.99% increase from the last price of 51.10.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.97
Sales
$24.9M
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -135.37%
 
 
 
 
 
 
Growthannually -77.76%
 
 
 
 
 
 

Sales

Growthquarterly -21.71%
 
 
 
 
 
 
Growthannually -7.25%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.